Tempest Therapeutics (TPST)

• Market cap: $30.9M
• 1 day: 6.02%
• 5 days: 2.23%
• 1 month: -4.58%
• 3 months: -26.6%
• 6 months: -75.77%
• Year to date: -22.37%
• 1 year: -78.25%
• 5 years: -99.48%
• 10 years: -99.99%
• Sector: Healthcare
• Industry: Biotechnology

About: Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Employees: 5